Latest Profitability News

AFT Pharmaceuticals has reported a robust first half of FY26, posting a 33% revenue increase to a record $114.9 million and returning to profitability amid strong growth in Australia and international markets. The company’s advancing R&D pipeline and strategic licensing deals position it well for ambitious FY27 targets.

The a2 Milk Company has raised its FY26 revenue guidance, citing stronger-than-expected performance in key product categories and favourable currency movements. The company anticipates solid earnings growth and robust cash flow conversion.

Finbar Group Limited highlights strong sales momentum in 2025, underpinned by a $1.2 billion development pipeline and a buoyant Western Australian apartment market driven by migration and undersupply.

Tasmea Limited reported a stellar FY25 with strong revenue and profit growth, bolstered by strategic acquisitions and a robust dividend payout. The company signals continued momentum with a new acquisition announcement and targets ASX300 inclusion in 2026.

Tasmea Limited reported robust FY25 financial results with a 74% jump in net profit after tax, driven by organic growth and strategic acquisitions. The company reaffirmed its FY26 guidance, supported by a $43 million institutional placement to fuel further expansion.

Schaffer Corporation delivered solid FY25 results with revenue growth and record property valuations, but the Jaguar Land Rover cyberattack clouds the near-term outlook for its Automotive Leather division.

Schaffer Corporation reported a 10% decline in statutory net profit for FY25, driven by mixed segment performances, while maintaining dividends and advancing key property developments.

Clime Investment Management has agreed to sell its retail client book for $1.65 million, marking a strategic shift to focus on its wholesale business and high-net-worth clients.

Nufarm Limited reported a 3% revenue increase to $3.4 billion in FY2025, driven by strong crop protection growth, while restructuring in Seed Technologies led to a statutory loss of $165 million. The company forecasts earnings growth and leverage reduction in FY2026.

Nufarm’s FY25 results reveal robust growth in crop protection and a strategic reset in seed technologies, with a significant reduction in net debt setting the stage for a stronger FY26.

Nufarm Limited posted a $165.3 million statutory loss for FY25, driven by significant restructuring charges and omega-3 price declines, while announcing a CEO transition effective January 2026.

Whitefield Industrials reported a 4% decline in net profit for the half-year to September 2025 but maintained a strong fully franked dividend and delivered portfolio returns above its benchmark.